Rinovum Women’s Health, a Monroeville, PA-based women’s health company, secured $3m in Series C financing.
The round was led by a Pennsylvania-based investment fund with participation from the PLSG Accelerator Fund and BlueTree Allied Angels.
Led by Steve Bollinger, CEO, Rinovum received FDA clearance for over-the-counter use of its product in July 2014 and, to date, has launched in three markets: the United Kingdom, Canada and the United States. The Stork products (The Stork® and The Stork® OTC) give couples a way to use cervical cap insemination — an established conception technique — in private. The Stork OTC incorporates familiar elements (condom-like sheath for collection and tampon-like delivery and removal of the cap), so it can be used in private, before having to try in-clinic treatments (or after having already tried them).
FinSMEs
19/12/2014